Our InVivo Plus antibodies are specifically formulated for direct in vivo administration in preclinical animal studies. Each antibody meets the most stringent purity standards: ultra-low endotoxin (≤0.001 EU/µg), azide-free, carrier protein-free, and sterile-filtered in physiological buffer (PBS, pH 7.0). Ready for injection without additional purification or buffer exchange. All products are designated Research Use Only (RUO) — not intended for diagnostic or therapeutic procedures. RUO
Mouse
in vivo PD-L1 blockade, in vitro PD-L1 blockade, IF, IHC-F, FCM, WB
Rat
Monoclonal
IgG2b kappa
10F.9G2
Mouse
in vivo blocking of PD-1/PD-L signaling
Rat
Monoclonal
IgG2a kappa
RMP1-14
Mouse
FCM, in vivo CD8+ T cell depletion, Western blot, Neutralization
Rat
Monoclonal
lgG2b kappa
2.43
Mouse
FCM, IF, IHC, Neutralization, WB
Rat
Monoclonal
IgG2a kappa
29F.1A12
Rat
FCM, Isotype Control
Rat
Monoclonal
IgG2a kappa
SPE-7
Mouse
FCM, Isotype Control, In vivo Control
Mouse
Monoclonal
IgG1 kappa
X40
Human
FCM, Isotype Control, In vivo Control
Human
Monoclonal
IgD kappa
HyHEL-10
Human
FCM, Isotype Control
Human
Monoclonal
IgG1 lambda
HyHEL-10
Mouse
in vivo blocking of VEGF/VEGFR-2 signaling, in vitro blocking of VEGFR signaling, WB
Rat
Monoclonal
IgG1 kappa
DC101
Mouse
in vivo TNFα neutralization, in vitro TNFα neutralization, WB
Rat
Monoclonal
IgG1 kappa
XT3.11